Exacerbation Reduction Over Three Years with Beclometasone/Formoterol/Glycopyrronium in Asthma: Real-World Evidence from the TriMaximize Study (ERS 2026) - May 30, 2026 - Abstract #OA6628; Pres time: Sep 8, 2026; 03:00 PM - 03:05 PM; Location: 3J.; Board Number: 10; "Significant and sustained reduction in exacerbations was observed over a three-year period in patients with moderate to severe asthma treated with BDP/FF/G."
Clinical • HEOR • Real-world • Real-world evidence • Asthma • Immunology • Respiratory Diseases
|
|
F. Trinkmann; V. Bogoevska; R. Russell; C. Ulrik; W. Pohl; V. Plaza; A. Bourdin; M. Kupczyk; F. Braido; A. Hahn; C. Fritz; V. Grickschat; C. Gessner
|